Insider Transactions in Q2 2022 at Psychemedics Corp (PMD)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2022
|
Raymond C Kubacki Jr Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+7.34%
|
-
|
|
May 20
2022
|
Michael I Schaffer VP of Laboratory Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+11.73%
|
-
|
|
May 20
2022
|
Andrew Limbek Vice President & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+33.55%
|
-
|
|
May 20
2022
|
Charles M Doucot Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+21.99%
|
-
|
|
May 20
2022
|
Andrew Reynolds Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+46.15%
|
-
|
|
May 20
2022
|
Walter S Tomenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+13.89%
|
-
|
|
May 20
2022
|
Fred J Weinert Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+14.36%
|
-
|
|
May 20
2022
|
Robyn C Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+32.43%
|
-
|
|
May 13
2022
|
Raymond C Kubacki Jr Chairman, CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,725
-0.74%
|
$10,350
$6.44 P/Share
|
|
May 13
2022
|
Michael I Schaffer VP of Laboratory Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
337
-1.02%
|
$2,022
$6.44 P/Share
|
|
May 13
2022
|
Charles M Doucot Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
900
-3.11%
|
$5,400
$6.44 P/Share
|
|
May 13
2022
|
Andrew Limbek Vice President & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
600
-8.04%
|
$3,600
$6.44 P/Share
|
|
Apr 20
2022
|
Peter Kamin Director |
BUY
Open market or private purchase
|
Indirect |
7,558
+2.42%
|
$45,348
$6.72 P/Share
|
|
Apr 20
2022
|
Peter Kamin Director |
BUY
Open market or private purchase
|
Direct |
8,100
+3.65%
|
$48,600
$6.72 P/Share
|
|
Apr 19
2022
|
Peter Kamin Director |
BUY
Open market or private purchase
|
Indirect |
27,485
+5.37%
|
$164,910
$6.52 P/Share
|
|
Apr 08
2022
|
Peter Kamin Director |
BUY
Open market or private purchase
|
Indirect |
4,000
+1.91%
|
$24,000
$6.79 P/Share
|
|
Apr 07
2022
|
Peter Kamin Director |
BUY
Open market or private purchase
|
Indirect |
3,000
+1.47%
|
$18,000
$6.68 P/Share
|
|
Apr 05
2022
|
Fred J Weinert Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.65%
|
$4,000
$4.07 P/Share
|
|
Apr 05
2022
|
Andrew Reynolds Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+50.0%
|
-
|